Annapurna Therapeutics SAS (extinct)

Annapurna Therapeutics SAS (extinct)

Annapurna Therapeutics SAS (extinct)

Overview
Date Founded

2014

Headquarters

183, avenue de Choisy,Paris, Ile-de-France 75013

Type of Company

Private

Employees (Worldwide)

1 - 10

Industries

Biotechnology
IT Consulting & Services
Hospitals & Patient Services
Pharmaceuticals
Medical Support Services

Company Description

Annapurna Therapeutics SAS operates as a gene therapy company. Its therapy restored cardiac function and reversed pathological heart enlargement in mice that had already progressed to heart failure. The company was founded by Pierre Bougneres, Hélène Puccio, Amber Salzman, Patrick Aubourg and Ronald G. Crystal and is headquartered in Paris, France.

Paths to Annapurna Therapeutics SAS
Potential Connections via
Relationship Science
You
Annapurna Therapeutics SAS
Recent Transactions
Details Hidden

Adverum Biotechnologies, Inc. purchases Annapurna Therapeutics SAS

Transaction Advisors
Legal Advisor

Advised onAdverum Biotechnologies, Inc. purchases Annapurna Therapeutics SAS

Legal Advisor

Advised onAdverum Biotechnologies, Inc. purchases Annapurna Therapeutics SAS

Legal Advisor

Advised onAdverum Biotechnologies, Inc. purchases Annapurna Therapeutics SAS

Investors
Details Hidden

Partner at Versant Venture Management LLC

Details Hidden

Managing Partner at INSERM Transfert SA

Details Hidden

Venture Partner at Versant Venture Management LLC

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Annapurna Therapeutics SAS. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Annapurna Therapeutics SAS's profile does not indicate a business or promotional relationship of any kind between RelSci and Annapurna Therapeutics SAS.